XML 22 R13.htm IDEA: XBRL DOCUMENT
v3.22.2.2

EARNINGS PER SHARE | 6 Months Ended
--- | ---
Sep. 30, 2022
EARNINGS PER SHARE |
EARNINGS PER SHARE | NOTE 6 - EARNINGS PER SHARE Basic EPS is computed by dividing reported earnings available to stockholders by the weighted average shares outstanding. Diluted EPS also includes the effect of stock options that would be dilutive. The following table provides a reconciliation of the numerators and denominators reflected in the basic and diluted earnings per share computations for the three months ended: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months ended | ​ | Three Months ended | ​ | Six Months ended | ​ | Six Months ended
​ |  | September 30, 2022 |  | September 30, 2021 |  | September 30, 2022 |  | September 30, 2021
Basic EPS | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net income (loss) | ​ | $ | 390,944 | ​ | $ | (220,413) | ​ | $ | (110,221) | ​ | $ | 1,150,679
Weighted average shares | ​ |  | 34,338,040 | ​ |  | 31,359,941 | ​ |  | 34,322,828 | ​ |  | 30,424,216
Net income (loss) per share | ​ | $ | 0.01 | ​ | $ | (0.01) | ​ | $ | (0.00) | ​ | $ | 0.04
Diluted EPS | ​ |  | ​ | ​ |  | ​ | ​ |  | ​ | ​ |  | ​
Net income (loss) | ​ | $ | 390,944 | ​ | $ | (220,413) | ​ | $ | (110,221) | ​ | $ | 1,150,679
Dilutive effect of stock options | ​ |  | 1,654,740 | ​ |  | -- | ​ |  | -- | ​ |  | 1,602,046
Weighted average shares | ​ |  | 35,992,780 | ​ |  | 31,359,941 | ​ |  | 34,322,828 | ​ |  | 32,026,262
Net income (loss) per share | ​ | $ | 0.01 | ​ | $ | (0.01) | ​ | $ | (0.00) | ​ | $ | 0.04
​ All potential common stock equivalents that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS. For the six months ended September 30, 2022, there were potential anti-dilutive stock options and warrants of 1,668,495, none of which were included in the earnings per share calculations above. For the three months ended September 30, 2021, there were potential anti-dilutive stock options and warrants of 1,660,922, none of which were included in the earnings per share calculations above.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI https://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration